Gervais, Anne

Publishing since 1990 (Senior)

Has published 36 publications in 20 years

Number of publications published per year by Gervais, Anne. (Source : PubMed)

Distribution of publications types for Gervais, Anne. (Source : PubMed)
(a publication can be of different types, so total may exceed publications count)

Recent publications

•  Gervais A, Eymard JC, Toulmonde E, Bernard J. Selected allogeneic dendritic cells markedly enhance human tumour antigen-specific T cell response in vitro.  Cancer Immunol. Immunother.  2009;58;11  
•  O'Loughlin J, Gervais A, Dugas E, Meshefedjian G. Milestones in the process of cessation among novice adolescent smokers.  Am J Public Health  2009;99;3  
•  Gallien S, Bigé N, Kitzis MD, Longuet P, Gervais A, Leport C. Drug-to-drug interaction between dapsone and minocycline: an unusual cause of relapse of toxoplasmic encephalitis in an HIV-infected patient.  Scand. J. Infect. Dis.  2009;41;9  
•  Neau D, Trimoulet P, Pereira E, Lafon ME, Gervais A, Ragnaud JM, Dupon M, Ecobichon JL, Chêne G, Raffi F. Evolution of plasma hepatitis C virus load in patients coinfected by HIV and hepatitis C Virus started on a protease inhibitor-containing antiretroviral regimen, Agence Nationale de Recherches sur le SIDA CO8 APROCO-COPILOTE cohort.  J. Acquir. Immune Defic. Syndr.  2008;48;2  
•  Gervais A, Longuet P, Leport C. A success story: universal vaccination in Italy--what has to be done to eradicate residual acute hepatitis B?  Clin. Infect. Dis.  2008;46;6  
•  Piroth L, Lafon ME, Binquet C, Bertillon P, Gervais A, Lootvoet E, Lang JM, De Jaureguiberry JP, Chene G, Leport C. Occult hepatitis B in HIV-HCV coinfected patients.  Scand. J. Infect. Dis.  2008;40;10  
•  Essig M, Duval X, Kaied FA, Iordache L, Gervais A, Longuet P, Blanchet F, Peytavin G, Leport C. Is phosphatemia the best tool to monitor renal tenofovir toxicity?  J. Acquir. Immune Defic. Syndr.  2007;46;2  
•  Toutirais O, Gervais A, Cabillic F, Le Gallo M, Coudrais A, Levêque J, Catros-Quemener V, Genetet N. Effects of CD40 binding on ovarian carcinoma cell growth and cytokine production in vitro.  Clin. Exp. Immunol.  2007;149;2  
•  Eymard JC, Gervais A, Jarcau R, Bernard J. [State of the art about new therapeutic vaccines in prostate cancer: dendritic cells, engineered tumor cells and recombinant virus]  Bulletin du cancer  2007;94;7 Suppl  
•  Gervais A, Toutirais O, Bouet-Toussaint F, De la Pintiere CT, Genetet N, Catros-Quemener V. In vitro antitumor lymphocyte generation using dendritic cells and innate immunity mechanisms as tumor cell treatments.  Anticancer Res.  2007;27;4B  

[ See timeline ] [ See all publications ]